In addition, proteomic analysis of serum-derived EVs of cancer patients and healthy individuals identified seven upregulated proteins in EVs of cancer patients, one of which was protein CD5L, which might act as a potential biomarker for the early detection of this disease from serum samples [64]. Here, CD5L is linked to cancer.